Franklin Resources Inc Kronos Bio, Inc. Transaction History

Franklin Resources Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.12 - $7.52 $741,574 - $1.79 Million	-237,684 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$6.26 - $14.42 $1.45 Million - $3.35 Million	-232,099 Reduced 49.41%	237,684 $1.72 Million
Q4 2021 Feb 11, 2022	BUY	$11.35 - $21.18 $34 - $63	3 Added 0.0%	469,783 $6.38 Million
Q3 2021 Nov 12, 2021	BUY	$18.17 - $24.7 $4.61 Million - $6.27 Million	253,872 Added 117.58%	469,780 $9.85 Million
Q2 2021 Aug 13, 2021	BUY	$20.08 - $29.02 $319,272 - $461,418	15,900 Added 7.95%	215,908 $5.17 Million
Q4 2020 Feb 10, 2021	BUY	$26.68 - $38.23 $5.34 Million - $7.65 Million	200,008 New	200,008 $5.97 Million

12.7M

51.2K

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $50M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.